1 2 Endoplasmic reticulum (ER) stress is associated with dysregulated metabolism, but little is 3 known about how the ER responds to metabolic activity. Here, working primarily in mouse 4 hepatocytes, we show that decreasing the availability of substrate for the TCA cycle diminished 5 NADPH production and attenuated ER stress in a manner that depended on glutathione 6 oxidation. ER stress was also alleviated by impairing either TCA-dependent NADPH production 7 or Glutathione Reductase. Conversely, stimulating TCA activity favored NADPH production, 8 glutathione reduction, and ER stress. Validating these findings, we show that deletion of the 9 mitochondrial pyruvate carrier, which is known to decrease TCA cycle activity and protect the 10 liver from diet-induced injury, also diminished NADPH, elevated glutathione oxidation, and 11 alleviated ER stress. These results provide independent genetic evidence that mitochondrial 12 oxidative metabolism is linked to ER homeostasis. Our results demonstrate a novel pathway of 13 communication between mitochondria and the ER, through relay of redox metabolites. 14 15 16
Introduction 1 2
As the gateway to the secretory pathway, the ER must properly synthesize and fold nascent 3 secretory and membrane proteins. Disruption of this process, known as ER stress, is associated 4 with many disease states, including obesity and its comorbidities (Mohan, R, Brown, Ayyappan, 5 & G, 2019). Thus, it is important to understand how ER homeostasis is perturbed, particularly by 6 metabolic disruption. The ER and the mitochondrial network, although not connected to each 7 other by secretory pathway traffic, are intertwined both physically and functionally. The ER 8 makes close physical contacts with mitochondria to facilitate the exchange of metabolites 9 (Raffaello, Mammucari, Gherardi, & Rizzuto, 2016; Vance, 2014; Yoboue, Sitia, & Simmen, 10 2018). The ER also communicates with mitochondria via signaling from the unfolded protein 11 response (UPR), which is activated by ER stress and signals through the three ER-resident 12 stress sensors IRE1, PERK, and ATF6 (Walter & Ron, 2011) . The UPR regulates mitochondrial 13 activity at several levels, including enhancing mitochondrial protein quality control, augmenting 14 ER-mitochondrial interactions and calcium signaling, and contributing to mitochondrial 15 depolarization and initiation of apoptosis (Y. Fan & Simmen, 2019; Gutierrez & Simmen, 2018; 16 Rainbolt, Saunders, & Wiseman, 2014). While the pathways through which ER stress and the 17 UPR regulate mitochondrial function are becoming clearer, the converse-how mitochondrial 18 function impacts ER homeostasis-is less understood . 19 In the liver, the UPR suppresses a large number of genes involved in metabolic 20 processes (Rutkowski et al., 2008) . One of the processes suppressed is fatty acid b-oxidation 21 (DeZwaan-McCabe et al., 2017), which takes place in mitochondria. The role of the UPR is to 22 restore ER function during stress, suggesting that suppressing b-oxidation in the mitochondria is 23 functionally beneficial to achieving ER homeostasis. However, it is not clear how metabolic 24 activity within the mitochondria might be conveyed to the ER. 25 been shown to be a source of electrons for reduction and isomerization of disulfide bonds of ER 1 client proteins (Poet et al., 2017) . The oxidized form of glutathione (GSSG), which predominates 2 in the ER lumen compared to the cytosol, was formerly thought to reoxidize protein disulfide 3 isomerase (PDI) to promote ER disulfide bond formation. However, since the discovery of 4 alternative pathways for PDI reoxidation (Frand & Kaiser, 1999; Tu, Ho-Schleyer, Travers, & 5 Weissman, 2000; Zito, Melo, et al., 2010) , the role of glutathione in the ER is now much less 6 clear (Delaunay-Moisan, Ponsero, & Toledano, 2017; Tsunoda et al., 2014) . Whether elevated 7 GSSG might be beneficial to ER function under some cellular conditions but detrimental in 8 others is also unknown. 9
Despite the centrality of the TCA cycle to cellular function and hints that its activity might 10 be tied to ER stress (Mogilenko et al., 2019; Xin et al., 2018) , its involvement in ER homeostasis 11 has not been investigated. Here, we used primary hepatocytes and other metabolically active 12 cell types to investigate the relationship between metabolic activity and ER stress. We show that 13 TCA cycle activity links lipid and carbohydrate catabolism to ER homeostasis through 14 production of NADPH and redox regulation of glutathione. Our findings delineate a novel 15 mechanism of communication from mitochondria to the ER, reveal an unexpected protective 16 role for GSSG, and provide a plausible pathway by which ER homeostasis is linked to metabolic 17 activity. 18 19 Results 1 2 Inhibition of b-oxidation alleviates ER stress in metabolically active cell types 3 We have previously shown in vivo and in hepatoma cells in vitro that inhibiting b-oxidation either 4 pharmacologically or genetically diminishes ER stress signaling (Tyra, Spitz, & Rutkowski, 5 2012) . In order to identify the pathway by which b-oxidation and ER homeostasis are linked, we 6 first asked whether etomoxir, which blocks b-oxidation by inhibiting the CPT1-dependent 7 transport of fatty acyl-CoAs into the mitochondria for oxidation (Weis, Cowan, Brown, Foster, & 8 McGarry, 1994; Yao et al., 2018) , could diminish ER stress signaling in primary hepatocytes in 9 vitro as it does in the liver in vivo. Treatment of primary hepatocytes with the ER stressor 10 tunicamycin (TM) upregulated UPR-responsive mRNAs, whereas etomoxir cotreatment 11 suppressed this effect ( Figure 1A ). Dampened ER stress signaling was also evident from 12 diminishment of the splicing of the IRE1a nuclease target Xbp1 ( Figure 1B ) and of the 13 upregulation of the stress-regulated factor CHOP ( Figure 1C ). Because these events are 14 differentially regulated by the three limbs of the UPR, our data suggest that etomoxir diminishes 15 signaling from all three UPR pathways. This result is consistent with our previous findings, in 16 which ER stress signaling in hepatoma cells was diminished by etomoxir, by inhibition of b-17 oxidation with a separate agent, and by knockdown of CPT1 (Tyra et al., 2012) . 18 We next determined if the apparent protective effects of etomoxir were limited to one cell 19 type or to one ER stressor. Using the selection of UPR-regulated mRNAs in Figure 1A as a 20 broad indicator of ER stress signaling, we found that etomoxir also diminished UPR activation in 21 C2C12 myoblasts ( Figure 1D ), and immortalized (data not shown) and primary ( Figure 1E ) 22 brown adipocytes. Hepatocytes, myocytes, and brown adipocytes are characterized by 23 particularly high lipid metabolic activity (Frayn, Arner, & Yki-Jarvinen, 2006) . In contrast, 24 etomoxir had no significant effect on the expression of UPR target genes in primary mouse 25 embryonic fibroblasts ( Figure S1 ). In primary hepatocytes subjected to ER stress by palmitate 1 loading, etomoxir likewise diminished ER stress signaling ( Figure 1G ). (As expected, the 2 unsaturated fatty acid oleate did not cause ER stress.) Palmitate is thought to elicit ER not by 3 disrupting protein folding per se but by altering ER membrane fluidity, activating the UPR stress 4 sensors through their transmembrane domains (Volmer, van der Ploeg, & Ron, 2013). Thus, 5 etomoxir diminishes ER stress induced by stressors that act by divergent mechanisms. 6
The effects of etomoxir on ER stress signaling could be due to improvement of ER 7 homeostasis in some way, or to simple inhibition of UPR signaling. We did not observe any 8 robust differences in the efficiency with which ER client proteins were secreted in hepatocytes 9 treated with etomoxir compared to those that were not treated (data not shown). However, as a 10 separate assessment of ER homeostasis, we examined ER ultrastructure in hepatocytes treated 11 with TM, with or without etomoxir. Consistent with previous reports (Finnie, 2001; Rutkowski et 12 al., 2006) , TM elicited marked ER dilation accompanied by a loss of lamellar structure and 13 overall disorganization, although some areas of grossly normal ER were present and were 14 predominantly juxtaposed near mitochondria. In contrast, these disruptions were largely 15 prevented by cotreatment with etomoxir ( Figure 2A ) as confirmed by two independent, blinded 16 scorers ( Figure 2B ). Although etomoxir diminished ER stress signaling, it did not block it 17 entirely. Higher doses of TM elicited UPR activation in etomoxir-treated cells to an extent 18 comparable to that observed with lower doses in non-etomoxir-treated cells ( Figure 2C ). 19
Therefore, the UPR in etomoxir-treated cells remained competent for signaling. Together, these 20 results suggest that inhibiting b-oxidation alleviates ER stress. 21
To provide a direct test of whether etomoxir could alleviate ER stress caused by the 22 accumulation of misfolded protein, we examined its ability to reverse ER stress associated with 23 overexpression of the null Hong Kong (NHK) protein. NHK is encoded by a nonsense mutation 24 of a1-antitrpysin that results in a truncated product which is retained in the ER and undergoes 25 ER-associated degradation, resulting in ER stress in diverse cell types ( Wu et al., 2007) . We transduced primary hepatocytes with a 3 recombinant adenovirus expressing NHK under doxycycline (Dox)-inducible control (Ad-TetOn-4 NHK). As a control, cells were transduced with adenovirus constitutively overexpressing GFP 5 instead (Ad-GFP). No ER stress was observed in Ad-TetOn-NHK-transduced cells in the 6 absence of Dox (not shown). As expected, Dox treatment elicited ER stress in cells transduced 7
with Ad-TetOn-NHK, but not in cells expressing Ad-GFP. The stress induced by NHK was 8 markedly diminished by etomoxir ( Figure 3A ). Overexpression of NHK disrupted ER structure, 9
resulting in the appearance of structurally amorphous ER puncta that were diminished by 10 etomoxir treatment ( Figure 3B ). This finding was again substantiated by blinded analysis of EM 11 images ( Figure 3C ). In principle, etomoxir treatment could alleviate NHK-dependent ER stress 12 by reducing protein synthesis. However, we found no evidence that global translation rates were 13 altered by etomoxir ( Figure S2 ). Consistent with this observation, we found that, 4 hours after 14 NHK induction, steady-state expression of NHK did not differ in cells treated or not with etomoxir 15 ( Figure 3D ). However, at later time points, we observed diminished steady state expression of 16 NHK in etomoxir-treated cells, and this distinction was lost when degradation of NHK was 17 blocked by the proteasomal inhibitor MG-132 ( Figure 3D ). While the mechanisms by which 18 etomoxir enhances ERAD remain under investigation, these results provide a separate line of 19 evidence that inhibiting b-oxidation improves ER homeostasis, perhaps by affecting misfolded 20 protein clearance. 21
22
Inhibiting b-oxidation protects ER function through glutathione redox 23 We and others have previously shown that etomoxir raises the cellular ratio of oxidized (GSSG) 24
to reduced (GSH) glutathione (Merrill et al., 2002 ; Pike, Smift, Croteau, Ferrick, & Wu, 2010; 25 Tyra et al., 2012) . Given the association of GSSG with the oxidative protein folding environment 1 in the ER, we examined whether etomoxir could make the ER more oxidizing to proteins in the 2 lumen. This was done by monitoring the oxidation of albumin, an endogenous hepatocyte ER 3 client protein that forms 17 disulfide bonds (Peters & Davidson, 1982) . We tested the resistance 4 of albumin to reduction by treating cells with DTT, lysing them, and then modifying free 5 sulfhydryls with PEG-maleimide, which retards migration upon SDS-PAGE (Winther & Thorpe, 6 2014 ). We found that treatment with DTT led to almost complete reduction of albumin in 7 otherwise untreated cells, whereas etomoxir caused a significant increase in the preponderance 8 of albumin that remained oxidized ( Figure 4A ). These results suggest that glutathione redox 9 might mediate the protective effects of etomoxir. 10
To first determine if glutathione redox plays a role in the protective effects of etomoxir, 11
we used 2-AAPA to inhibit glutathione reductase Zhao et al., 2009 ), an 12 enzyme with both mitochondrial and cytosolic activity that couples NADPH oxidation to GSSG 13 reduction. We predicted that this treatment would phenocopy the protective effects of etomoxir. 14 As expected, treatment with 2-AAPA diminished cellular GSH levels and increased GSSG, thus 15 significantly elevating the GSSG/GSH ratio, similar to the effects of etomoxir ( Figure 4B ). Also 16 similarly to etomoxir, 2-AAPA treatment alleviated ER stress, as determined by attenuated Xbp1 17 splicing ( Figure 4C ) and diminished upregulation of UPR target genes ( Figure 4D ). Therefore, 18
inhibiting glutathione reduction phenocopies the protective effects of etomoxir. 19 We next tested the converse prediction: that promoting glutathione reduction would 20 cause ER stress. We treated hepatocytes with auranofin, which inhibits redox-active 21 selenoproteins, including thioredoxin reductases and, at the dose used here, glutathione 22 peroxidases (Chaudiere & Tappel, 1984; Roberts & Shaw, 1998; Scarbrough et al., 2012) . In 23 the liver, glutathione peroxidase 1 is two orders of magnitude more abundant than any 24 thioredoxin reductase (Lai, Kolippakkam, & Beretta, 2008) . Therefore, presumably due to its 25 effects on glutathione peroxidase, auranofin treatment elevated cellular GSH levels and 26 diminished GSSG, leading to a decrease in the GSSG/GSH ratio ( Figure 5A ). The relative 1 resistance of albumin to reduction by DTT upon treatment with auranofin suggested that the ER 2 environment was more reducing, whereas treatment with 2-AAPA made it more oxidizing 3 ( Figure 5B ). Auranofin treatment alone was sufficient to induce a modest level of ER stress, 4 seen in upregulation of UPR target genes in the absence of any other ER stress stimulus 5 ( Figure 5C ). More importantly, auranofin completely blocked the ability of etomoxir to alleviate 6 ER stress ( Figure 5D ). This epistatic relationship suggests that the protective effect of etomoxir 7 requires glutathione oxidation. 8 9
TCA cycle activity links oxidative metabolism to ER homeostasis 10
Although glutathione reductase uses NADPH to reduce glutathione, b-oxidation yields NADH 11 and FADH2 but not NADPH. However, b-oxidation yields acetyl-CoA, which enters the TCA 12 cycle by condensation with oxaloacetate for further oxidation. We therefore speculated that 13 etomoxir might diminish production of NADPH from the TCA cycle, thereby resulting in elevated 14
GSSG. In this model, it is not b-oxidation per se that is linked to ER homeostasis, but rather 15 TCA cycle activity and the resultant production of NADPH. This model first predicted that 16 etomoxir would diminish levels of both acetyl-CoA and NADPH-predictions which we then 17 confirmed ( Figure 6A , B). The model also predicted that impairing TCA-dependent NADPH 18 production would elevate the GSSG/GSH ratio and alleviate ER stress, similarly to etomoxir 19 treatment. Three TCA cycle isozymes generate NADPH: mitochondrial isocitrate 20 dehydrogenase 2 (IDH2) and cytosolic IDH1 and malic enzyme (ME1). (The NADPH-producing 21 mitochondrial ME3 is not expressed in the mouse liver). Using siRNAs, we specifically knocked 22 down mRNA expression of each of these ( Figure 6C ). Knockdown of each gene diminished 23 GSH levels, and knockdown of Idh2 and Me1 also increased GSSG levels, thus elevating the 24 GSSG/GSH ratio ( Figure 6D ). Further, ER stress was diminished by knockdown of each of the 1 three genes ( Figure 6E ). 2
The Pyruvate Dehydrogenase complex oxidizes pyruvate produced by glycolysis to 3 acetyl-CoA, and is a major control point of TCA cycle activity for carbohydrate metabolism 4 Dichloroacetate treatment substantially elevated the NADPH/NADP+ ratio ( Figure 7A ). In 9 addition, dichloroaceetate treatment alone caused ER stress to an extent that was nearly as 10 robust as the bona fide ER stressor TM, as seen by upregulation of UPR target genes ( Figure  11 7B) and splicing of Xbp1 ( Figure 7C ). Therefore, these data provide direct evidence that 12 mitochondrial oxidative catabolic activity causes ER stress. availability for oxidation in the TCA cycle. To test this prediction, we first examined the effects of 26 deleting MPC1 by CRISPR in C2C12 myocytes. We found that loss of MPC1 diminished the 1 NADPH/NADP+ ratio and elevated the GSSG/GSH ratio in these cells ( Figure 8A, B ). 2
Diminished UPR activation at both the protein ( Figure 8C ) and mRNA ( Figure 8D ) levels 3 indicated that MPC1-deficient cells were also remarkably resistant to ER stress induced by TM 4 or by the ER calcium-disrupting agent thapsigargin (TG). These findings were confirmed in 5 primary hepatocytes taken from mice lacking MPC2 in the liver (Mpc2 LKO ), when compared to 6 cells from mice with an intact allele (Mpc2 fl/fl ). In cells lacking MPC2, both the upregulation of 7 UPR target genes ( Figure 8E ) and Xbp1 mRNA splicing ( Figure 8F , G) were attenuated. These 8 findings provide direct genetic evidence that ER homeostasis is responsive to the availability of 9 TCA cycle substrates. Our results elucidate a pathway by which the ER senses metabolic activity ( Figure 9 ). We 3 propose that NADPH and GSSG convey TCA cycle status: decreasing the availability of acetyl-4
CoA-either from lipid or carbohydrate catabolism-dampens NADPH production and disfavors 5 glutathione reduction, with the increased GSSG ultimately rendering the ER lumen more 6 oxidizing and protecting ER homeostasis. Conversely, enhancing acetyl-CoA availability 7 ultimately favors GSH over GSSG and causes ER stress. That these relationships were seen in 8 hepatocytes, myocytes, and brown adipocytes, but were conspicuously absent in fibroblasts, 9
hints that oxidative metabolism might represent an intrinsic challenge to ER functionality and 10 might explain why feeding itself appears to be an ER stressor. Although there are many 11 potential reasons that it might benefit the cell to tie ER protein processing to TCA cycle status-12 for example amino acid availability, ATP supply, lipid availability, etc.-the one we currently 13 favor is the balancing of the cellular redox budget. Both the oxidation of nutrients in the 14 mitochondria and the oxidation of nascent proteins in the ER generate toxic reactive oxygen 15 species (ROS): in the mitochondria by electron leakage during oxidative phosphorylation 16 (Murphy, 2009) , and in the ER by catalysis of disulfide bond formation by ER oxidoreductase 17 (ERO1) (Higa & Chevet, 2012) . That inhibiting b-oxidation renders the ER more oxidizing 18
suggests that the cell might be able to safely oxidize nutrients or nascent proteins, but not both 19 simultaneously. As with the elucidation of any new pathway, our findings raise many further 20 questions about how the pathway is initiated and regulated, and how it ultimately impacts 21 cellular and organismal physiology. 22
That increased TCA activity elicits ER stress does not necessarily portend cellular 23 dysfunction. It is possible that ER stress induced by enhanced metabolic activity might "prime" 24 the ER by eliciting prophylactic ER stress. Brief exposures to stress are known to precondition 25 outside the context of overnutrition and obesity, transient. Insulin action on the liver during 1 feeding is known to promote both oxidative catabolism through PDH dephosphorylation ( While our data suggest that production of NADPH by the TCA cycle is a key event in our 7
proposed pathway, it is not yet clear how NADPH production corresponds to actual activity of 8 the cycle-given that metabolites can enter and exit the cycle at multiple points depending on 9 nutritional conditions-nor how the cellular compartmentalization of NADPH production 10 contributes to the transmission of the NADPH status to the ER. The NADPH/NADP+ ratio is 11 regulated by nutritional state, exercise, diet, and circadian rhythms (Bradshaw, 2019; Ying, 12 2008 thioredoxin reductase in the cytosol, and that cytosolic glutathione becomes more oxidized 26 because it must compensate in the reduction of reactive oxygen species for the shortage of 1 reduced thioredoxin. An alternate possibility is that cytosolic NADPH manipulation ultimately 2 affects matrix NADPH status through metabolite shuttles, which are used to convey reducing 3 equivalents across the mitochondrial membranes by coupling mitochondrial redox reactions with 4 their cytosolic counterparts (for example, using the transport of citrate to couple IDH2 and IDH1) 5 . A next step will be to determine how TCA activity affects compartmentalization of 6 NADPH arising from various sources. 7
Our results are surprising also in their implication that oxidized glutathione has a 8 beneficial role in ER function. It is well-established that reducing agents elicit ER stress and 9 activate the UPR, which speaks to the importance of the ER oxidative environment in the 10 protein folding process. However, reducing equivalents are needed as well in order to activate 11 ERO1 (Kim, Sideris, Sevier, & Kaiser, 2012) and to reduce disulfide isomerases so that they 12 can catalyze reduction of improper disulfide bonds (Schwaller, Wilkinson, & Gilbert, 2003) . protein oxidation capacity or stress sensitivity except for specialized substrates. It could be that 20 ER oxidative capacity and the relative need for oxidized glutathione varies by cell type. 21
An important question for future work is how elevated GSSG in the mitochondria and/or 22 cytosol is transmitted to the ER. Does a change in the total cellular GSSG/GSH ratio ultimately 23 change that ratio in the ER, or does GSSG exert its effects on the ER environment indirectly? 24
To date, no mechanism for import of GSSG into the ER has been described. One possibility is 25 that diminishing the cytosolic level of GSH suppresses its import into the ER, thereby elevating 26 the ER GSSG/GSH ratio as well. However, given that the ratio of GSH to GSSG in the cytosol is 1 approximately 100:1, it seems unlikely that cytosolic GSH is limiting in this way. Alternatively, 2 perhaps sites of ER-mitochondrial contact facilitate spatially restricted exchange of glutathione 3 as they do for other metabolites such as calcium and reactive oxygen species (Joseph, Booth, 4 Young, & Hajnoczky, 2019). Ultimately, determining how elevated GSSG outside the ER leads 5 to a more oxidizing ER lumen will require compartment-specific monitoring and manipulation of 6 the glutathione redox state. 7
Our results also raise the question of what aspect(s) of ER functional capacity are 8 altered by TCA cycle activity and glutathione redox. Activation of the UPR generally serves as a 9 readout for ER stress, but it is not clear what diminished ER stress implies in terms of an actual 10 accumulation of unfolded proteins, particularly because some stressors, such as palmitate 11 loading, activate the UPR apparently independent of the protein folding process (Volmer et al., 12 2013 ). There are relatively few approaches for disentangling truly dysfunctional protein 13 processing from the criteria by which the UPR perceives ER stress, which are still not well 14 understood. For example, one might expect a dysfunctional ER to secrete proteins more slowly; 15 on the other hand, perhaps enhanced ER retention time and chaperone association of client 16 proteins facilitates proper protein folding under stressful conditions. In any case, we have yet to 17 find any robust differences in nascent ER protein trafficking, processing, or aggregation in cells 18 in which TCA activity is manipulated other than apparently enhanced clearance of NHK ( Figure  19 4D). It remains to be determined whether this effect extends to other substrates and cell types. 20
One intriguing-but speculative-possibility is that GSSG might paradoxically protect the ER by 21 exacerbating protein misfolding, if doing so renders misfolded client proteins more readily 22 recognized and either refolded or cleared rather than futilely engaged with the ER quality control 23 machinery. Whatever the case, we infer that inhibiting TCA activity actually protects ER 24 homeostasis in part because of its effects on ER ultrastructure. In principle, a hyperoxidizing ER 25 might simply blunt the UPR rather than improve ER function, since activation of at least the UPR 26 sensors ATF6 and IRE1 can be inhibited by oxidation (Nadanaka, Okada, Yoshida, & Mori, 1 2007; J. M. Wang et al., 2018) . However, there is no evidence that enforcing reduction of these 2 sensors is sufficient for their activation, meaning there would then be no reason to expect DCA 3 to cause ER stress on its own. Moving forward, the redox status and activity of BiP will be of 4 particular interest, given its roles in protein folding, ERAD, protein translocation, and UPR whether NAFLD progression is accelerated by ER stress arising from this increased flux, and 25 whether diminished hepatic TCA flux in mice lacking MPC activity protects the liver at least in 26 part by alleviating or preventing ER stress. On one hand, oxidative stress is recognized to 1 contribute to NAFLD progression, and glutathione is known to protect against NAFLD 2 progression (Liu, Baker, Baker, & Zhu, 2015), although most of those studies have examined 3 glutathione synthesis rather than glutathione redox. Conversely, our observation of elevated 4 GSSG in cells lacking MPC1 ( Figure 8B) suggests that, at a minimum, GSSG is not 5 incompatible with diminished sensitivity to NAFLD. Whether TCA-dependent NADPH production 6 contributes to NAFLD is not known. IDH1 and IDH2 function in vivo has mostly been examined 7 in the context of transforming mutations in gliomas that change IDH activity. Both IDH1 and 8 IDH2 are widely expressed, and to our knowledge no liver-specific deletion of either has been 9 created. Thus, the role of the axis identified here in NAFLD has not been directly tested. 10
In conclusion, we have identified a novel NADPH-and glutathione-dependent pathway 11 through which TCA cycle activity impacts ER homeostasis. We expect that this pathway will be 12 relevant to the physiology and pathophysiology of liver, muscle, adipose, and other highly 13 metabolically active cell types. 14
Materials and Methods 1 2
Cell culture and drug treatments 3 Primary hepatocytes were isolated from mice of both sexes between 6-12 weeks of age. Mice 4 were anesthetized with isoflurane for the duration of the isolation. The liver was perfused 5 through the portal vein with freshly prepared Perfusion Medium followed by digestion with Liver 6
Digest Medium. Media formulas were as follows: Liver Perfusion Medium: HBSS, no calcium, no 7 magnesium, no phenol red (Life Technologies, Carlsbad, CA), 0.5 mM EDTA, 0.5 mM EGTA, 25 8 mM HEPES, and penicillin-streptomycin (10,000 U/mL); Liver Digest Medium: HBSS, calcium, 9 magnesium, no phenol red, 25 mM HEPES, penicillin-streptomycin (10,000 U/mL), 3. Tris-tricine or Tris-HCl SDS-PAGE gels and transferred to 0.45 µm Immobilon-P Polyvinylidene 25 Fluoride (PVDF) (Millipore) for Western blotting using ECL Prime substrate (GE Healthcare). 1 qRT-PCR, including primer validation by standard curve and melt curve analysis, was as 2 described (Rutkowski et al., 2006) . Briefly, RNA was isolated following the standard Trizol 3 protocol and RNA oncentrations were obtained using the Qubit RNA Broad Range kit. 4
Concentrations were normalized, and cDNA was synthesized using 400 ng RNA with 5
PrimeScript RT Master Mix (Takara). PCR reactions were performed using TB Green Premix Ex 6
Taq (Takara) in a CFX96 cycler (Bio-Rad). Oligonucleotide sequences are listed in Table 1 . Two 7 loading controls were included in each experiment (Btf3 and Ppia). Conventional RT-PCR was 8 performed to assess splicing of Xbp1 as described (Tyra et al., 2012) . 9 Figure S1. ET treatment does not diminish ER stress in primary mouse embryonic fibroblasts. Primary mouse embryonic fibroblasts treated were treated with 25 μg/ml ET and 250 ng/ml TM as indicated for 8h. mRNA expression was assessed by qRT-PCR as in Figure 1 . Figure S2 . ET treatment does not affect protein synthesis. Primary hepatocytes treated were treated with 25 μg/ml ET and 250 ng/ml TM as indicated in media with 10 percent the normal amount of methionine and cysteine, and EasyTag ExpreSS 35 S (Perkin Elmer NEG772002MC) was added to a final concentration of 50 μCi/ml. After the indicated times, cell lysates were collected in 1% SDS 100 mM Tris, pH 8.8, denatured by heating, spotted onto gridded 3MM filter paper, and air dried. Filter was then precipitated by serial incubations in ice-cold 10% trichloroacetic acid (TCA) for 60 min., 5% TCA at room temperature for 5 min., 5% TCA preheated to 75 o for 5 min., 5% TCA at room temperature for 5 min., and finally 2:1 ethanol:ether preheated to 37 o for 5 min. Filter was then air dried, sliced into individual samples, and immersed in scintillation cocktail, and counted. n = 6 samples per condition. The modest effect of this dose of TM on protein synthesis is consistent with previous findings (Rutkowski et al., 2006) 
